1. Home
  2. VANI vs ORKT Comparison

VANI vs ORKT Comparison

Compare VANI & ORKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VANI
  • ORKT
  • Stock Information
  • Founded
  • VANI 1998
  • ORKT 2003
  • Country
  • VANI United States
  • ORKT Singapore
  • Employees
  • VANI N/A
  • ORKT N/A
  • Industry
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ORKT
  • Sector
  • VANI Health Care
  • ORKT
  • Exchange
  • VANI Nasdaq
  • ORKT NYSE
  • Market Cap
  • VANI 68.1M
  • ORKT N/A
  • IPO Year
  • VANI 2014
  • ORKT 2024
  • Fundamental
  • Price
  • VANI $1.27
  • ORKT $0.55
  • Analyst Decision
  • VANI Strong Buy
  • ORKT Strong Buy
  • Analyst Count
  • VANI 1
  • ORKT 1
  • Target Price
  • VANI $4.00
  • ORKT $5.00
  • AVG Volume (30 Days)
  • VANI 148.9K
  • ORKT 254.6K
  • Earning Date
  • VANI 08-12-2025
  • ORKT 01-01-0001
  • Dividend Yield
  • VANI N/A
  • ORKT N/A
  • EPS Growth
  • VANI N/A
  • ORKT N/A
  • EPS
  • VANI N/A
  • ORKT N/A
  • Revenue
  • VANI N/A
  • ORKT $2,962,282.00
  • Revenue This Year
  • VANI N/A
  • ORKT $9.63
  • Revenue Next Year
  • VANI N/A
  • ORKT N/A
  • P/E Ratio
  • VANI N/A
  • ORKT N/A
  • Revenue Growth
  • VANI N/A
  • ORKT N/A
  • 52 Week Low
  • VANI $0.91
  • ORKT $0.40
  • 52 Week High
  • VANI $1.50
  • ORKT $8.00
  • Technical
  • Relative Strength Index (RSI)
  • VANI 61.03
  • ORKT N/A
  • Support Level
  • VANI $1.13
  • ORKT N/A
  • Resistance Level
  • VANI $1.33
  • ORKT N/A
  • Average True Range (ATR)
  • VANI 0.07
  • ORKT 0.00
  • MACD
  • VANI 0.00
  • ORKT 0.00
  • Stochastic Oscillator
  • VANI 63.64
  • ORKT 0.00

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

Share on Social Networks: